Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
- Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival +12021 | First Faculty of Medicine
- Myasthenia - a dreaded diagnosis? : Everything you need to know about your illness2021 | First Faculty of Medicine
- Neuropsychiatry: a clinical guide for outpatient and clinical practice2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monitoring of radiologic disease activity by serum neurofilaments in MS +12020 | First Faculty of Medicine
- Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis2020 | First Faculty of Medicine
Loading network view...